Abstract:Objective To observe the effect of recombinant human endostatin (endostar) in combination with radiation on hepatic carcinoma xenografts in mice under different timing of administration, endostar dose and radiation dose.Methods (1) The xenotransplanted tumor model of human hepatic carcinoma in mice was established.The mice were randomly grouped based on timing of administration, endostar dose and radiation dose, with 10 mice in each group.The length and diameter of xenografts were measured every other day.The tumor suppress effect was compared between early administration and late administration manners.(2) The mice were divided into 6 groups with 30 mice in each group and treated in early administration manner.Then the overall survival was observed.(3) MTT assay was used to observe the synergistic effect influenced by the dose of endostar and radiation.(4) Western blotting was used to detect the expression of epidermal growth factor (EGF) and vascular endothelial growth factor receptor-1(Flt-1) in early and late administration manners.(5) Immunochemistry was used to test the expression of vascular endothelial growth factor (VEGF) and KDR, as well as microvascular density of hepatic carcinoma xenografts.(6) Cyto-apoptosis was observed by electron microscope and cell cycles and apoptotic rates were determined by flow cytometry.Results Compared with control group, endostar could suppress the growth of hepatic carcinoma xenografts (P<0.05), and early administration manner performed better than late administration manner (P<0.05).Synergistic effect was found in 8 mg/kg endostar+RT group of early administration manner, and the tumor suppress rate was 58.0%, better than other groups (P<0.05).The median overall survival of 8 mg/kg endostar+RT group was 55.6 days with the life prolonging rate of 29.3%, better than other groups (P<0.05).5 μg/ml endostar in combination with 4Gy radiation on HUVECs cells showed synergistic effect with the proliferative inhibition rate of 59.20%, better than other doses of endostar (P<0.05).200 μg/ml endostar in combination with 4 Gy radiation on HepG2 cells showed synergistic effect with the proliferative inhibition rate of 43.45%, better than other doses of endostar (P<0.05).5 μg/ml endostar in combination with different doses of radiation on HUVECs, as well as 200 μg/ml endostar in combination with different doses of radiation on HepG2 cells both showed better proliferative inhibition rates than using endostar or radiation alone (P<0.05).Western blotting test showed that the expressions of EGF in 8 mg/kg endostar group and 8 mg/kg endostar+RT group of early administration manner was lower than those of late administration manner.However, the expression of Flt-1 between the two manners had no difference (P>0.05).Endostar in combination with radiation could significantly decrease MVD of hepatic carcinoma xenografts, the MVD in 8 mg/kg endostar+RT group was 8.6±1.3, lower than other groups (P<0.05).In 8 mg/kg endostar+RT group, the expression of VEGF and KDR was lower than other groups (P<0.05).Apoptoic changes were observed under lectron microscope in endostar in combination with radiation groups.Flow cytometry showed that cell cycles were blocked in S phase in 8 mg/kg endostar+RT group, and the cyto-apoptotic rate was higher than other groups (P<0.05).Conclusion The synergistic effect of endostar in combination with radiation is correlated to timing of administration, endostar dose and radiation dose, and the effect of early administration of endostar is superior to the late.

The effect of rh-endostatin in combination with radiotherapy on the HIF-1α and VEGF expression in mice with lung cancer

The Effect of rh-Endostatin in Combination with Radiotherapy on the Tumor Growth and VEGF Expression in Mice with Lung Cancer

[Effects of rh-endostar in combination with radiotherapy on rats with lung cancer].

An Experimental Research into Endostatin Microbubble Combined with Focused Ultrasound for Anti-Tumor Angiogenesis in Colon Cancer

Effect of Endostar Combined with Radiotherapy on the Expression of HIF-1α,AQP1 and VEGF in the Mice with Lung Caner

Effect of Endostar Combined with Radiotherapy on the Expression of Aquaporin 1 and Hypoxia-Inducible Factor-1 Alpha Mrna and Growth of Mice with Lewis Lung Cancer

Inhibitory Effect of Radiotherapy Combined with Weekly Recombinant Human Endostatin on the Human Pulmonary Adenocarcinoma A549 Xenografts in Nude Mice

Effect of Endostar Combined with Radiotherapy on the Expressions of HIF-1 and VEGF in Lung Adenocarcinoma A549 Cell

Synergistic Inhibitory Effects of Endostatin and Radiation Therapy on Angiogenesis of Lewis Lung Cancer in Nude Mice

[The Effect of Endostatin and Radiotherapy on Human Lung Cancer Cell Line A549 and the Impact of HIF-1 Expression after Therapy.].

Effect of Recombinant Human Endostar Combined with Radiotherapy on Expression of Carbonic Anhydrase Ⅸ and E-cadherin in Lewis Lung Cancer Xenograft Model

The dose and time factors on synergistic effects of the combination of endostar and radiation against hepatic carcinoma xenografts in mice

Enhanced radioresponse with a novel recombinant human endostatin protein via tumor vasculature remodeling: Experimental and clinical evidence

Endostar down-regulates HIF-1 and VEGF expression and enhances the radioresponse of lung cancer

Effect of endostar combined with radiotherapy on expression of integrin αvβ3 mRNA and MVD in lung cancer of Lewis rats

Endostar Enhances the Radioresponse on Lewis Lung Carcinoma by Regulating HIF-1&#x03B1;

Effect of recombinant human endostatin on radiosensitivity in patients with non-small-cell lung cancer.

Ad-Endostatin Treatment Combined with Low-Dose Irradiation in A Murine Lung Cancer Model

Anti-tumor Effect of Pegr-1-endostatin-tnf-α Recombinant Plasmid Expression Induced by Ionizing Radiation

Impacts of endostatin on expression of vascular endothelial growth factor receptor-2 in non-small cell lung cancer cells and mechanisms underlying its radiosensitizing effect

[Combined Effects of Endostatin Gene Transfer and Ionizing Radiation on Lung Adenocarcinoma Model of A549-cells].